Arch Gen Psychiatry -- Table of Contents (Vol. 49 No. 9, September 1992)

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Table of Contents

ARTICLES

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder
L. R. Baxter Jr; J. M. Schwartz; K. S. Bergman; M. P. Szuba; B. H. Guze; J. C. Mazziotta; A. Alazraki; C. E. Selin; H. K. Ferng; P. Munford; al. et
Arch Gen Psychiatry. 1992;49:681-689.
ABSTRACT

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy
S. E. Swedo; P. Pietrini; H. L. Leonard; M. B. Schapiro; D. C. Rettew; E. L. Goldberger; S. I. Rapoport; J. L. Rapoport; C. L. Grady
Arch Gen Psychiatry. 1992;49:690-694.
ABSTRACT

Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography
R. T. Rubin; J. Villanueva-Meyer; J. Ananth; P. G. Trajmar; I. Mena
Arch Gen Psychiatry. 1992;49:695-702.
ABSTRACT

Risks of affective illness among first-degree relatives of bipolar I old-order Amish probands
D. L. Pauls; L. A. Morton; J. A. Egeland
Arch Gen Psychiatry. 1992;49:703-708.
ABSTRACT

An intriguing association between ancestral mortality and male affective disorder
G. E. Vaillant; D. Roston; G. J. McHugo
Arch Gen Psychiatry. 1992;49:709-715.
ABSTRACT

Major depression and generalized anxiety disorder. Same genes, (partly) different environments?
K. S. Kendler; M. C. Neale; R. C. Kessler; A. C. Heath; L. J. Eaves
Arch Gen Psychiatry. 1992;49:716-722.
ABSTRACT

Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers
S. S. Smith; B. F. O'Hara; A. M. Persico; D. A. Gorelick; D. B. Newlin; D. Vlahov; L. Solomon; R. Pickens; G. R. Uhl
Arch Gen Psychiatry. 1992;49:723-727.
ABSTRACT

Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples
J. Biederman; S. V. Faraone; K. Keenan; J. Benjamin; B. Krifcher; C. Moore; S. Sprich-Buckminster; K. Ugaglia; M. S. Jellinek; R. Steingard; al. et
Arch Gen Psychiatry. 1992;49:728-738.
ABSTRACT

Toward a neuroanatomy of obsessive-compulsive disorder
T. R. Insel
Arch Gen Psychiatry. 1992;49:739-744.

There is more than one way to collect data for linkage analysis. What a study of epilepsy can tell us about linkage strategy for psychiatric disease
D. A. Greenberg
Arch Gen Psychiatry. 1992;49:745-750.
ABSTRACT

Zacopride in schizophrenia: a single-blind serotonin type 3 antagonist trial
J. W. Newcomer; W. O. Faustman; R. B. Zipursky; J. G. Csernansky
Arch Gen Psychiatry. 1992;49:751-752.

Fluoxetine inhibits desipramine metabolism
T. E. Wilens; J. Biederman; R. J. Baldessarini; S. P. McDermott; P. R. Puopolo; J. G. Flood
Arch Gen Psychiatry. 1992;49:752.